Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Clinical trial NCT05522660 · RECRUITING
Trial details
- NCT number
- NCT05522660
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2026-09-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.